Olmesartan/Amlodipin Abz (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin Abz, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults. It combines olmesartan with a calcium‑channel blocker to improve blood pressure control.

GNH USA supplies Olmesartan/Amlodipin Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipin Abz is used for cardiovascular conditions that require blood pressure reduction. - Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Chronic kidney disease with hypertension: Helps protect renal function by maintaining target blood pressure. - Heart failure with reduced ejection fraction: Supports after‑load decrease and symptom control.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Peripheral edema - Headache - Flushing - Dizziness - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Hepatic enzyme elevation - Myocardial infarction - Atrioventricular block - Hyperkalemia

When prescribing Olmesartan/Amlodipin Abz, clinicians should consider several safety aspects. - Monitor blood pressure: Ensure target levels are reached without excessive fall. - Assess renal function: Adjust use in patients with impaired kidneys. - Check electrolytes: Watch for potassium abnormalities. - Review cardiac history: Use cautiously in patients with heart block or severe aortic stenosis. - Pregnancy and lactation: Avoid use; teratogenic risk is possible. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Olmesartan/Amlodipin Abz may interact with several concomitant medicines.

Major Interactions (Avoid): - Concomitant use with > 5 mg lithium or potassium‑sparing diuretics. - Strong CYP 3‑5 inducers such t t t.\n g  g

Major ...